Kevin J Galinsky

4PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 17, 2026
A Phase 2, Open-Label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.

|Jul 27, 2022
Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease.

Ruben Y Gabriëls, Arno R Bourgonje, Julius Z H von Martels

|Jan 04, 2022
Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor.

José Á García-Sáenz, Noelia Martínez-Jáñez, Ricardo Cubedo

|Apr 06, 2021
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.

Bora Lim, David A Potter, Mohamad A Salkeni

Pageof 1

Frequent Collaborators

2 joint publications

Sylvie Vincent

1 joint publications

José Á García-Sáenz

1 joint publications

Yolanda Jerez

1 joint publications

Santiago González-Santiago